莫诺帕制药 MNPR
$71.42 +$4.20 (+6.25%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $73.00 +2.21%
开盘$68.02
昨收$67.22
当日区间$67.31 – $72.25
成交量94.2K
市值$479.38M
市盈率（TTM）–
股息率–
MNPR 相关新闻
匹配 Monopar Therapeutics 或代码 MNPR 的头条新闻，按最新排序。
- Piper Sandler Maintains Monopar Therapeutics(MNPR.US) With Buy Rating, Raises Target Price to $123 正面
- H.C. Wainwright Maintains Monopar Therapeutics(MNPR.US) With Buy Rating, Maintains Target Price $125
- H.C. Wainwright Reaffirms Their Buy Rating on Monopar Therapeutics Inc (MNPR)
- Barclays Maintains Monopar Therapeutics(MNPR.US) With Buy Rating, Raises Target Price to $145 正面
- Morgan Stanley Maintains Monopar Therapeutics(MNPR.US) With Buy Rating, Raises Target Price to $130 正面
- A Quick Look at Today's Ratings for Monopar Therapeutics(MNPR.US), With a Forecast Between $125 to $133
- Barclays Maintains Monopar Therapeutics(MNPR.US) With Buy Rating, Maintains Target Price $125
- Morgan Stanley Maintains Monopar Therapeutics(MNPR.US) With Buy Rating, Maintains Target Price $115
- H.C. Wainwright Maintains Monopar Therapeutics(MNPR.US) With Buy Rating, Raises Target Price to $125 正面
- BTIG Maintains Monopar Therapeutics(MNPR.US) With Buy Rating, Maintains Target Price $117
- Lake Street Maintains Monopar Therapeutics(MNPR.US) With Buy Rating, Maintains Target Price $103
- A Quick Look at Today's Ratings for Monopar Therapeutics(MNPR.US), With a Forecast Between $101 to $130
- BTIG Maintains Monopar Therapeutics(MNPR.US) With Buy Rating, Raises Target Price to $117 正面
- H.C. Wainwright Maintains Monopar Therapeutics(MNPR.US) With Buy Rating, Maintains Target Price $105
- Piper Sandler Maintains Monopar Therapeutics(MNPR.US) With Buy Rating, Maintains Target Price $101
暂无评论——快来第一个聊聊 MNPR。
登录后参与讨论。